Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Biden administration calls for crackdown on misleading Medicare ads
Dec 15, 2022
The new rule would ban ads that have confusing words, imagery or logos or that do not specifically mention a health insurance plan by name.
Medicare eligibility linked to improvements in healthcare access
Oct 04, 2022
For low-income adults, Medicare eligibility was linked to a reduction in the percentage delaying or avoiding medical care due to cost.
Medicare monthly premiums to drop for seniors
Sep 28, 2022
The fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10%.
Peritoneal dialysis less costly for Medicare than hemodialysis
Aug 24, 2022
A convergence in the costs of intravenous dialysis drugs was seen between peritoneal dialysis and hemodialysis.
Medicare could have saved $3.6 billion on generic drugs in 2020
Jun 20, 2022
The authors say that Medicare could have saved up to $3.6 billion by purchasing generics at Mark Cuban Cost Plus Drug Co. prices.